Polygenic Scores (PGSs) in the National Longitudinal Study of Adolescent to Adult Health (Add Health) – Release 1 by Braudt, David & Harris, Kathleen Mullan
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CAROLINA POPULATION CENTER | CAROLINA SQUARE - SUITE 210 | 123 WEST FRANKLIN STREET | CHAPEL HILL, NC 27516 
Funding Acknowledgements: This report was funded by grant R01 HD073342 from the Eunice Kennedy Shriver National Institute of Child Health 
and Human Development (NICHD). Data for this study come from Add Health, a program project directed by Kathleen Mullan Harris and designed 
by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-
HD31921 from NICHD, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. 
Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the 
Add Health website (http://www.cpc.unc.edu/addhealth). Additional support was received from the Population Research Training grant (T32 
HD007168) and the Population Research Infrastructure Program (P2C HD050924) awarded to the Carolina Population Center at The University 
of North Carolina at Chapel Hill by NICHD. 
 
Add Health Documentation 
Polygenic Scores (PGSs) in the National Longitudinal Study  of Adolescent to Adult Health (Add Health) – Release 1 
Report prepared by 
David B. Braudt 
Kathleen Mullan Harris 
2018 
Table of Contents 
Overview ...................................................................................................................................................................4 
Data ..........................................................................................................................................................................5 
Genome-wide Data ...............................................................................................................................................5 
Ancestry Specific Samples ....................................................................................................................................5 
Methods ...................................................................................................................................................................7 
Polygenic Scores ...................................................................................................................................................7 
Ancestry-specific Principal Components ..............................................................................................................8 
A Note on Raw PGSs .................................................................................................................................................8 
Using Add Health PGSs .............................................................................................................................................9 
Citing this Document and Data .................................................................................................................................9 
Polygenic Scores .................................................................................................................................................... 12 
Coronary Artery Disease .................................................................................................................................... 13 
Myocardial Infarction ........................................................................................................................................ 15 
Plasma Cortisol .................................................................................................................................................. 17 
Low-density Lipoprotein (LDL) Cholesterol ....................................................................................................... 19 
High-density Lipoprotein (HDL) Cholesterol ...................................................................................................... 21 
Total Cholesterol ............................................................................................................................................... 23 
Triglycerides ....................................................................................................................................................... 25 
Type II Diabetes (2012) ...................................................................................................................................... 27 
Type II Diabetes (2014) ...................................................................................................................................... 29 
Body Mass Index ................................................................................................................................................ 31 
Waist Circumference ......................................................................................................................................... 33 
Waist-to-Hip Ratio ............................................................................................................................................. 35 
Height ................................................................................................................................................................ 37 
Menarche .......................................................................................................................................................... 39 
Menopause ........................................................................................................................................................ 41 
Number of Children Ever Born .......................................................................................................................... 43 
Age at First Birth ................................................................................................................................................ 45 
Ever/Current Smoker ......................................................................................................................................... 47 
Number of Cigarettes per day ........................................................................................................................... 49 
Extraversion ....................................................................................................................................................... 51 
Attention-Deficit/Hyperactivity Disorder (2010) ............................................................................................... 53 
3 
 
Attention-Deficit/Hyperactivity Disorder (2017) ............................................................................................... 55 
Bipolar Disorder ................................................................................................................................................. 57 
Major Depressive Disorder (2013) .................................................................................................................... 59 
Major Depressive Disorder (2018) .................................................................................................................... 61 
Schizophrenia .................................................................................................................................................... 63 
Mental Health Cross Disorder ........................................................................................................................... 65 
Alzheimer’s Disease ........................................................................................................................................... 67 
Educational Attainment (2016) ......................................................................................................................... 69 
Educational Attainment (2018) ......................................................................................................................... 71 
 
 
4 
 
Overview 
Research has shown that many outcomes of interest in the health, behavioral, and social sciences are 
influenced by genetics (Domingue et al. 2016; Plomin et al. 2016; Turkheimer 2000). For most human 
traits/behaviors, commonly referred to as phenotypes, it appears that the genetic influence on the phenotype 
is highly polygenic; i.e., there is no single gene that can account for the association between genetic variance 
and the outcome. Instead, the influence of genetics on the phenotype appears to be due to many small 
associations across thousands, and possibly millions, of individual single-nucleotide polymorphisms (SNPs, 
pronounced snips) (Chabris et al. 2015). Polygenic Scores allow researchers to avoid the methodological 
complexities of including thousands, or millions, of covariates in their analyses by condensing, into a single 
measure, the associations between individual SNPs and the phenotype of interest (Plomin, Haworth, and Davis 
2009).  
 
Polygenic Scores (PGSs), sometimes referred to as polygenic risk scores or genetic risk scores, 
represent a general measure of the influence of additive genetics on a specific phenotype. The calculation of 
PGSs relies on summary statistics from genome-wide association studies (GWASs) to create a weighted sum of 
the associations between allele frequencies at individual SNPs and the associated phenotype. The estimated 
associations, i.e. beta-coefficients, for each SNP from a GWAS, conducted on a large independent sample, are 
multiplied by the allele frequencies of the same SNPs for individuals in the sample for which the PGS is being 
created. This process yields a hypothesis free measure of the cumulative additive genetic influences on the 
phenotype being studied. PGSs are hypothesis free because they aggregate the individual associations between 
SNPs and the phenotype, thus removing the possibility of investigating links between specific biological/genetic 
pathways and the phenotype. While the hypothesis free nature of PGSs dilutes the ability to detect biological 
pathways, it allows researchers to capture the broad influence of genetics in various analyses (Belsky and Israel 
2014; Dudbridge 2016).  
 
Since PGSs represent the associations between SNPs across the entire genome and a phenotype in a 
single measure, they can easily be incorporated into many of the quantitative analyses common in economics 
(Benjamin et al. 2012), sociology (Conley 2016), social stratification (Braudt forthcoming), as well as other 
social, behavioral, and health sciences (Belsky and Israel 2014). The PGSs described in this document are meant 
to facilitate the use of PGSs among users of the National Longitudinal Study of Adolescent to Adult Health (Add 
Health).   
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Data  
Add Health is an ongoing nationally representative longitudinal study of adolescents in the U.S. who were in 
grades 7-12 in 1994-5. Wave I (1994-5, 79% response rate) included a sample of 80 high schools and 52 middle 
schools chosen from a stratified sample according to region, urbanicity, school size, school type, and racial and 
ethnic composition with probability of selection proportional to size. With five waves of data—Wave II (1996, 
89% response rate), Wave III (2001-2, 77% response rate), Wave IV (2008, 80% response rate), and Wave V 
(2016-18, in the field)—and information on adolescents’ fellow students, school administrators, parents, 
siblings, friends, and romantic pairs, as well as extensive longitudinal geospatial data on neighborhood 
measures such as income, poverty, unemployment, the availability and use of health services, crime, religious 
membership, and social programs, Add Health represents one of the richest longitudinal studies of health and 
behavior in the U.S. available today. For more information on the Add Health study design see Harris (2013). 
 
 
Genome-wide Data 
As part of the Wave IV data collection, saliva samples were obtained from consenting participants (96% of 
Wave IV respondents). Approximately 12,200, or 80% of those participants, consented to long-term archiving 
and were consequently eligible for genome-wide genotyping. Genotyping was done on two Illumina platforms, 
with approximately 80% of the sample genotyping performed with the Illumina Omni1-Quad BeadChip and 
20% genotyped with the Illumina Omni2.5-Quad BeadChip. After quality control procedures, genotyped data 
are available for 9,974 individuals (7,917 from the Omni1 chip and 2,057 from the Omni2 chip) on 609,130 
SNPs common across both genotyping platforms (Highland, Heather M.; Avery, Christy L.; Duan, Qing; Li, Yun; 
Mullan Harris, Kathleen 2018). For more information on the genotyping and quality control procedures see the 
Add Health GWAS QC report online 
at: http://www.cpc.unc.edu/projects/addhealth/documentation/guides/copy_of_AH_GWAS_QC.pdf. 
        
Ancestry Specific Samples 
To account for population stratification,1 we restrict the Add Health genotyped sample to four genetic ancestry 
groups: European ancestry, African ancestry, Hispanic ancestry, and East Asian ancestry. To identify 
respondents in these four genetic ancestry groups we use principal component analysis on all unrelated 
members of the full Add Health genotyped sample and project those estimates onto the small remainder of 
related individuals. Figure 1 provides a visual depiction of this process with the respective cut-offs for inclusion 
in the genetic ancestry groups are represented by the black rectangles.  
Each ancestry group is defined by distance from the mean of the first two principal components of the 
genetic data as shown in Figure 1. To be included in the Hispanic, East Asian, and European ancestry groups 
                                                          
1 Population stratification refers to differences in genetic variation between geographical ancestry groups. Due to the 
genetic bottle neck created by the small number of humans (roughly 2,000 individuals) who migrated out of Africa early in 
human history, and the tendency for people to procreate with individuals from the same or nearby geographic regions, 
genetic variance across the entire genome is highly correlated with geography (for a more detailed discussion see Conley 
and Fletcher 2017:84–112). Importantly, genetic ancestry should not be confused with race or ethnicity. Race and 
ethnicity are social constructs based on a multitude of factors, of which ancestry may be included depending on historical 
and societal differences in racialization (Omi and Winant 1994). 
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Figure 1: Principal Components and Ancestry-Specific Samples 
 
 
Notes: (1) The principal components are estimated based on the allele frequencies of the 609,130 genotyped SNPs in the Add Health 
genome-wide data. (2) Black rectangles represent within Add Health genetic ancestry group boundaries. East Asian, Hispanic, and 
European ancestry groups are defined as: +/- 1 standard deviation from the within group mean of the first and second principal 
components estimated from individuals who self-identified as Asian, Hispanic, and non-Hispanic White respectively. African ancestry is 
defined as +/- 2 standard deviations from the mean of the first principal component and +/- 1 standard deviation from the mean of the 
second principal component estimated from all individuals in the genotyped sample who self-identified as non-Hispanic Black.  
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individuals must be within +/- 1 standard deviation of the mean of the first two principal components of the 
genetic data estimated from all individuals in the Add Health genome-wide data who self-identified as Hispanic, 
Asian, and non-Hispanic White respectively. To be included in the African ancestry group individuals must be 
within +/- 2 standard deviation of the mean of the first principal component and +/- 1 standard deviation of the 
mean of the second principal component estimated from all individuals in the genome-wide data who self-
identified as non-Hispanic Black. While genetic ancestry and self-identified race/ethnicity are strongly 
correlated (0.89), they are two separate constructs (see footnote 1). Consequently, not all individuals included 
in a given ancestry may self-identify or be socially-identified as the same race and/or ethnicity as other 
members of their ancestry group. Table 1 provides a depiction of the resulting sample sizes for each genetic 
ancestry group and their correspondence to self-identified race/ethnicity.   
 As a sensitivity analysis, we repeated the above process using group specific medians of the first two 
principal components of the genetic data as centroids instead of group means. While sample sizes for the four 
ancestry groups using the median as the centroid were comparable to those using the means of the principal 
components as centroids, in all cases, using the mean as the centroid resulted in larger sample size. Given the 
slight increase in sample size, we define within Add Health genetic ancestry groups as distance from the mean 
of the first two principal components of the genotyped data.   
 
Table 1: Add Health Polygenic Score Sample Sizes by Genetic Ancestry 
 Ancestry  
Self-Identified Race/Ethnicity European African East Asian Hispanic Total 
Non-Hispanic White 5,644 5 0 105 5,754 
Non-Hispanic Black 0 1,939 0 1 1,940 
Native American 14 2 0 7 23 
Asian 0 1 422 26 449 
Hispanic 70 27 15 849 961 
Missing 0 2 0 0 0 
Total Sample Size 5,728 1,976 437 988 9,129 
 
 
Methods 
Polygenic Scores 
We calculate polygenic scores (PGSs) following the procedure outlined in Dudbridge (2013). PGSs are a 
weighted sum of the regression coefficient for each SNP from an independent GWAS for each phenotype and 
allele frequencies for the same SNPs in the Add Health genome-wide data. For example, the raw PGS of 
educational attainment for an individual, 𝑖𝑖, is calculated as:   
 
(1) 
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𝑃𝑃𝑃𝑃𝑃𝑃𝐸𝐸𝐸𝐸𝐸𝐸𝑖𝑖 =�𝛽𝛽𝑗𝑗𝑃𝑃𝑆𝑆𝑃𝑃𝑖𝑖𝑗𝑗𝑘𝑘
𝑗𝑗=1
 
 
where, 𝑃𝑃𝑆𝑆𝑃𝑃𝑖𝑖𝑗𝑗 is the allele frequency of the 𝑗𝑗𝑡𝑡ℎ SNP for the 𝑖𝑖𝑡𝑡ℎ individual and 𝛽𝛽𝑗𝑗 is the estimated association 
between SNP 𝑗𝑗 and the number of years of education completed as reported in the GWAS summary statistics 
based on an independent sample (i.e. if a GWAS included Add Health, the GWAS is re-estimated excluding the 
Add Health sample and beta-weights from the re-estimated GWAS are used in Equation 1). To automate this 
process, we use a modified version of the PRSice wrapper for R within the PLINK software package (Chang et al. 
2015). Once calculated, the raw PGSs are standardized (𝜇𝜇𝑃𝑃𝑃𝑃𝑃𝑃 = 0 ∧ 𝜎𝜎𝑃𝑃𝑃𝑃𝑃𝑃 = 1) within ancestry groups. The 
standardization of PGSs within ancestry groups is done to account for between group population stratification. 
To control for within group population stratification, we recommend that researchers include at least the first 
five ancestry-specific principal components of the genome-wide data in all analyses using PGSs. It should be 
noted that these are imperfect controls, and PGSs should be re-calculated using GWAS weights for specific 
ancestry groups when such GWAS become available. 
 
Ancestry-specific Principal Components 
Ancestry-specific principal components are estimated following a similar procedure to the general principal 
components, with the sample restricted to individuals in the respective genetic ancestry groups. The process 
used starts with the genetic ancestry groups defined above, randomly removes one sibling of any sibling pairs 
in the data, estimates the first 20 principal components for all unrelated individuals in the ancestry specific 
sample, and then projects those principal components onto the small number of related individuals within each 
ancestry group.  
 
A Note on Raw PGSs 
We report a few descriptive statistics as well as density plots of the raw PGSs for each phenotype as calculated 
in Equation (1) above. While this information is presented for clarity and to ensure transparency, a few 
comments must be made on comparing raw PGSs between phenotypes and/or datasets.  
Raw PGSs, i.e. PGSs that have not been standardized within ancestry groups to have a mean = 0 and a 
standard deviation = 1, reported in this study are a function of the number of SNPs in the Add Health genome-
wide data that match SNPs for which the respective GWAS reports summary statistics (see Equation 1). Any 
differences in means, medians, and ranges of raw PGSs between datasets in which the number of SNPs in the 
genome-wide data differ between datasets is likely to primarily be a function of the beta weights for the non-
overlapping SNPs between the two datasets. Consequently, it’s unclear how, or if, such differences in the raw 
PGSs can be interpreted as evidence of “true” differences in a genetic propensity for the phenotype for which 
the PGS was created versus a methodological artifact stemming from differences in the number of genotyped 
SNPs included in the PGS calculations within each study. One possible alternative for researchers seeking to 
compare raw PGSs, based on the same GWAS summary statistics, between studies is to examine the relative 
distributions and variances of the raw PGSs. We provide density plots of the raw PGSs following the respective 
table of descriptive statistics for that PGS.  
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Similar to the above, comparing raw PGSs for two different traits, even if calculated from the same 
genome-wide sample, is not advised due to the fact that scores are dependent upon the weights from different 
GWASs. While there is considerable homogeneity between GWASs in how they are estimated, the type and 
number of controls, and method of meta-analysis, not all GWAS follow the same methodology, nor do they use 
the same sets of data. Consequently, it’s unclear what, if any, substantive meaning comparisons of raw PGSs 
for different phenotypes may have.    
 
Using Add Health PGSs  
Add Health is releasing PGSs for European, African, Hispanic, and East Asian genetic ancestry groups. However, 
researchers should be aware that PGSs for individuals not of the same ancestry group(s) as the GWAS from 
which summary statistics are retrieved may be less predictive (Martin et al. 2017; Ware et al. 2017). While 
there are several proposed explanations for this difference in predictive ability, one important reason is a lack 
of statistical power to account for population stratification between the ancestry group for which the PGS is 
calculated and the ancestry group(s) included in the GWAS. To help account for potential bias due to 
population stratification and/or differences in genetic structure within ancestry groups we include the first ten 
ancestry-specific principal components of the genetic data with the PGSs. It is strongly recommended that 
researchers perform analyses separately by ancestral groups or, at the very least, include the first five 
ancestry-specific principal components as covariates in analyses using these PGSs (Price et al. 2006).  
In order to minimize the risk of deductive disclosure, the order of the ancestry-specific principal 
components (PCS) of the genetic data are randomized in sets of five. Therefore, PCs must be included as sets: 
PC1-PC5, PC6-PC10, PC11-PC15, PC16-PC20 if any of the PCs of a set are included in analyses. For example, if a 
research wishes to include the first two ancestry-specific PCs as covariates in their analyses (i.e. PC1 and PC2) 
they must also include PC3-PC5. 
 
Citing this Document and Data 
Please include the following citation in any report, publication, and/or presentation based on the data in this 
release of the Add Health PGSs as well as the citation for the reference GWAS:  
Braudt, David B. and Kathleen Mullan Harris. 2018. “Polygenic Scores (PGSs) in the National Longitudinal Study  
of Adolescent to Adult Health (Add Health) – Release 1.” Chapel Hill, NC: Carolina Population Center, 
University of North Carolina at Chapel Hill.  
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Polygenic Scores  
In the following section we provide descriptions of each polygenic score (PGS) as well as the source of the 
GWAS summary statistics. In Table 2 we provide a list of phenotypes for which Add Health is releasing PGSs 
along with the ancestry group(s) included in the discovery GWAS analyses. Please read the section entitled 
“Using Add Health PGSs” in the introductory portion of this document prior to conducting any analyses using 
the provided PGSs. 
 
Table 2: PGS Phenotypes and Ancestry Groups included in the Respective GWAS 
 Phenotype GWAS Ancestry Group(s) 
Coronary Artery Disease European  
Myocardial Infarction European, South Asian, East Asian 
Plasma Cortisol European  
Low-density Lipoprotein Cholesterol European  
High-density Lipoprotein Cholesterol European  
Total Cholesterol  European  
Triglycerides European  
Type II Diabetes (2012) European  
Type II Diabetes (2014) European, East Asian, South Asian,  
Mexican/Mexican-American 
BMI European  
Waist Circumference European  
Waist-to-Hip Ratio European  
Height European  
Age at Menarche European  
Age at Menopause European  
Number of Children Ever Born European  
Age at First Birth  European  
Ever/Current Smoker  European  
Number of Cigarettes per day European  
Extraversion European  
Attention-deficit/hyperactivity Disorder (2010) European  
Attention-deficit/hyperactivity Disorder (2017) European, Chinese 
Bipolar Disorder European  
Major Depressive Disorder (2013) European  
Major Depressive Disorder (2018) European  
Schizophrenia European, East Asian  
Mental Health Cross Disorder  European  
Alzheimer's Disease European  
Educational Attainment (2016) European  
Educational Attainment (2018) European  
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Coronary Artery Disease  
GWAS Summary Statistic Source: Schunkert, Heribert et al. 2011. “Large-Scale Association Analysis Identifies 
13 New Susceptibility Loci for Coronary Artery Disease.” Nature Genetics 43(4):333–38. 
 
GWAS Ancestry Group(s): European   
 
 
The PGSs for coronary artery disease (CAD) were created using results from a 2011 study conducted by the 
Coronary ARtery DIsease Genome wide Replication and Meta-analysis (CARDIoGRAM) consortium. The GWAS 
meta-analysis files are publicly available and can be downloaded from: http://www.cardiogramplusc4d.org.  
 
The coronary artery disease GWAS meta-analysis consisted of 14 studies with a total of 22,233 individuals with 
CAD (cases) and 64,762 without CAD (controls) of European descent imputed to the HapMap3 CEU panel. 
Replication was performed in a sample of 56,682 individuals (approximately half cases and half controls). 
Study-specific GWAS adjusted for age of onset of CAD (cases) or age of recruitment (controls), gender, and 
genetic principal components.  
 
The Add Health PGSs for CAD are standardized (mean=0, standard deviation = 1) within ancestry groups to 
control for population stratification. To give researchers an idea of the underlying raw PGS, we present a few 
descriptive statistics and density plots for the unstandardized PGSs below. Please read the section entitled 
“Using Add Health PGSs” in the introductory portion of this document prior to conducting any analyses using 
the provided PGSs.  
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 497.54 692.85 590.53 590.56 0.32 
African ancestry 1976 522.15 663.65 601.36 601.46 0.44 
Hispanic ancestry 988 521.64 661.34 590.14 590.21 0.75 
Asian ancestry  437 508.46 618.88 570.86 569.82 0.96 
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Coronary Artery Disease  
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Myocardial Infarction  
GWAS Summary Statistic Source: Nikpay, Majid et al. 2015. “A Comprehensive 1,000 Genomes-Based 
Genome-Wide Association Meta-Analysis of Coronary Artery Disease.” Nature Genetics 47(10):1121–30. 
 
GWAS Ancestry Group(s): European (77%), South Asian (13% - India and Pakistan), East Asian (6% - China and 
Korea), Hispanic and/or African American (4%).  
 
 
The PGSs for myocardial infarction were created using 2015 results from a subgroup analysis of coronary artery 
disease conducted by the Coronary ARtery DIsease Genome wide Replication and Meta-analysis 
(CARDIoGRAM) consortium. The GWAS meta-analysis files are publicly available and can be downloaded 
from: http://www.cardiogramplusc4d.org.  
 
The GWAS is a meta-analysis of 48 studies of mainly European, South Asian, and East Asian, descent (as 
described above) imputed using the 1000 Genomes phase 1 v3 training set with 38 million variants. The study 
included 60,801 coronary artery disease cases and 123,504 controls. Case status was defined by an inclusive 
coronary artery disease diagnosis (for example, myocardial infarction, acute coronary syndrome, chronic stable 
angina or coronary stenosis of >50%). MI subgroup analysis was performed in cases with a reported history of 
MI (approximately 70% of the total number of cases).  
 
The Add Health PGSs for myocardial infarction (MI) are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification. To give researchers an idea of the underlying raw PGS, 
we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs.  
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -106.45 35.97 -35.42 -35.36 0.24 
African ancestry 1976 -42.45 67.83 16.87 17.06 0.33 
Hispanic ancestry 988 -78.06 61.43 -5.78 -5.65 0.67 
Asian ancestry  437 -11.68 96.54 42.74 42.24 0.77 
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Myocardial Infarction 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Plasma Cortisol  
GWAS Summary Statistic Source: Bolton, Jennifer L. et al. 2014. “Genome Wide Association Identifies Common 
Variants at the SERPINA6/SERPINA1 Locus Influencing Plasma Cortisol and Corticosteroid Binding Globulin.” 
PLOS Genetics 10(7):e1004474. 
 
GWAS Ancestry Group(s): Western European  
 
 
The PGSs for plasma cortisol were created using results from a 2014 GWAS conducted by the CORtisol NETwork 
(CORNET). The GWAS meta-analysis files are available through CORNET by request only.  
 
The discovery phase of the meta-analysis included 12,597 participants aged 14-102 of western European 
descent from 11 studies. The replication sample consisted of 2,795 participants from three independent 
cohorts: Raine Study (n=797), ET2DS (n=1,069), and MrOS-Sweden (n=929) (Bolton et al. 2014:8). Analyses 
were adjusted for age and sex. Additional sensitivity analyses showed no difference when time of sampling was 
included as a covariate.  
 
The Add Health PGSs for plasma cortisol (PI) are standardized (mean=0, standard deviation = 1) within ancestry 
groups to control for population stratification. To give researchers an idea of the underlying raw PGS, we 
present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -71.35 81.57 6.39 6.23 0.29 
African ancestry 1976 -65.44 72.37 -1.87 -1.52 0.42 
Hispanic ancestry 988 -88.81 69.20 -18.22 -18.46 0.79 
Asian ancestry  437 -114.93 5.76 -56.92 -57.72 0.96 
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Plasma Cortisol  
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Low-density Lipoprotein (LDL) Cholesterol 
GWAS Summary Statistic Source: Willer, Cristen J. et al. 2013. “Discovery and Refinement of Loci Associated 
with Lipid Levels.” Nature Genetics 45(11):1274–83. 
 
GWAS Ancestry Group(s):  European  
 
 
The PGSs for low-density lipoprotein cholesterol (LDL) were created using results from a 2013 GWAS conducted 
by the Global Lipids Genetics Consortium (GLGC). The GWAS meta-analysis files are publically available 
from: http://csg.sph.umich.edu/willer/public/lipids2013/.  
 
The discovery phase of the meta-analysis included 188,577 individuals of European ancestry from 45 studies, 
while the replication sample consisted of 7,898 individuals of non-European descent. Lipid levels were 
measured after eight or more hours of fasting with individuals taking lipid lowering medication excluded from 
the study. Study-specific GWAS adjusted for age, age-squared, sex, and genetic principal components.  
 
The Add Health PGSs for LDL are standardized (mean=0, standard deviation = 1) within ancestry groups to 
control for population stratification. To give researchers an idea of the underlying raw PGS, we present a few 
descriptive statistics and density plots for the unstandardized PGSs below. Please read the section entitled 
“Using Add Health PGSs” in the introductory portion of this document prior to conducting any analyses using 
the provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 3229.96 3306.87 3267.19 3267.37 0.13 
African ancestry 1976 3259.41 3310.81 3286.24 3286.08 0.17 
Hispanic ancestry 988 3240.91 3301.33 3270.43 3270.50 0.31 
Asian ancestry  437 3248.88 3301.42 3276.09 3276.33 0.38 
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Low-density Lipoprotein Cholesterol (LDL) 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
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Asian ancestry raw PGS distribution 
   
21 
 
High-density Lipoprotein (HDL) Cholesterol  
GWAS Summary Statistic Source: Willer, Cristen J. et al. 2013. “Discovery and Refinement of Loci Associated 
with Lipid Levels.” Nature Genetics 45(11):1274–83. 
 
GWAS Ancestry Group(s):  European  
 
 
The PGSs for high-density lipoprotein cholesterol (HDL) were created using results from a 2013 GWAS 
conducted by the Global Lipids Genetics Consortium (GLGC). The GWAS meta-analysis files are publically 
available from: http://csg.sph.umich.edu/willer/public/lipids2013/.  
 
The discovery phase of the meta-analysis included 188,577 individuals of European ancestry from 45 studies, 
while the replication sample consisted of 7,898 individuals of non-European descent. Lipid levels were 
measured after eight or more hours of fasting with individuals taking lipid lowering medication excluded from 
the study. Study-specific GWAS adjusted for age, age-squared, sex, and genetic principal components.  
 
The Add Health PGSs for HDL are standardized (mean=0, standard deviation = 1) within ancestry groups to 
control for population stratification. To give researchers an idea of the underlying raw PGS, we present a few 
descriptive statistics and density plots for the unstandardized PGSs below. Please read the section entitled 
“Using Add Health PGSs” in the introductory portion of this document prior to conducting any analyses using 
the provided PGSs. 
  
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 3030.99 3104.16 3071.52 3071.37 0.13 
African ancestry 1976 3040.33 3088.49 3065.20 3065.22 0.16 
Hispanic ancestry 988 3043.05 3104.31 3078.15 3077.90 0.30 
Asian ancestry  437 3074.88 3117.38 3093.48 3093.41 0.39 
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High-density Lipoprotein Cholesterol (HDL) 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
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Total Cholesterol  
GWAS Summary Statistic Source: Willer, Cristen J. et al. 2013. “Discovery and Refinement of Loci Associated 
with Lipid Levels.” Nature Genetics 45(11):1274–83. 
 
GWAS Ancestry Group(s):  European  
 
 
The PGSs for total cholesterol were created using results from a 2013 GWAS conducted by the Global Lipids 
Genetics Consortium (GLGC). The GWAS meta-analysis files are publically available 
from: http://csg.sph.umich.edu/willer/public/lipids2013/.  
 
The discovery phase of the meta-analysis included 188,577 individuals of European ancestry from 45 studies, 
while the replication sample consisted of 7,898 individuals of non-European descent. Lipid levels were 
measured after eight or more hours of fasting with individuals taking lipid lowering medication excluded from 
the study. Study-specific GWAS adjusted for age, age-squared, sex, and genetic principal components.  
 
The Add Health PGSs for total cholesterol (TC) are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification. To give researchers an idea of the underlying raw PGS, 
we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 3191.78 3276.87 3238.35 3238.20 0.15 
African ancestry 1976 3224.03 3279.23 3255.09 3254.85 0.18 
Hispanic ancestry 988 3209.34 3279.23 3246.01 3245.67 0.32 
Asian ancestry  437 3233.25 3283.98 3261.63 3261.40 0.39 
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Total Cholesterol (TC) 
European ancestry raw PGS distribution 
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Triglycerides  
GWAS Summary Statistic Source: Willer, Cristen J. et al. 2013. “Discovery and Refinement of Loci Associated 
with Lipid Levels.” Nature Genetics 45(11):1274–83. 
 
GWAS Ancestry Group(s):  European  
 
 
The PGSs for triglycerides were created using results from a 2013 GWAS conducted by the Global Lipids 
Genetics Consortium (GLGC). The GWAS meta-analysis files are publically available and can be downloaded 
from: http://csg.sph.umich.edu/willer/public/lipids2013/.  
 
The discovery phase of the meta-analysis included 188,577 individuals of European ancestry from 45 studies, 
while the replication sample consisted of 7,898 individuals of non-European descent. Lipid levels were 
measured after eight or more hours of fasting with individuals taking lipid lowering medication excluded from 
the study. Study-specific GWAS adjusted for age, age-squared, sex, and genetic principal components.  
 
The Add Health PGSs for triglycerides (TG) are standardized (mean=0, standard deviation = 1) within ancestry 
groups to control for population stratification. To give researchers an idea of the underlying raw PGS, we 
present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 2928.14 3007.00 2975.01 2974.60 0.14 
African ancestry 1976 2951.12 3000.56 2975.91 2975.91 0.15 
Hispanic ancestry 988 2951.06 3005.46 2979.39 2979.17 0.28 
Asian ancestry  437 2959.85 3013.48 2988.56 2988.87 0.36 
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Triglycerides (TG)
European ancestry raw PGS distribution 
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Type II Diabetes (2012) 
GWAS Summary Statistic Source: Morris, Andrew P. et al. 2012. “Large-Scale Association Analysis Provides 
Insights into the Genetic Architecture and Pathophysiology of Type 2 Diabetes.” Nature Genetics 44(9):981–90. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for Type II Diabetes 2012 were created using GWAS meta-analysis results from a 2012 study 
conducted by the DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. The GWAS meta-
analysis files are available from: http://www.diagram-consortium.org/downloads.html. 
 
The discovery meta-analysis consists of 12,171 T2D cases and 56,862 controls across 12 studies of populations 
of European descent. The replication meta-analysis consisted of 22,669 cases and 58,119 controls from studies 
of European populations and 1,178 cases and 2,472 controls from a study of Pakistani populations (Pakistan 
Risk of Myocardial Infarction Study). The authors note that they found little evidence of heterogeneity in SNP 
effects between European and Pakistani ancestry groups (p.981). Study-specific GWAS adjusted for age of 
onset (cases) or age of recruitment (controls), gender, and genetic principal components. Additionally, the 
results of each GWAS were corrected for residual population structure using the genomic control inflation 
factor, as reported in Supplementary Table 1 of Morris et al. (2012). 
 
The Add Health PGSs for Type II Diabetes 2012 (T2D_2012) are standardized (mean=0, standard deviation = 1) 
within ancestry groups to control for population stratification. To give researchers an idea of the underlying 
raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please 
read the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 10918.20 11236.00 11065.70 11066.84 0.48 
African ancestry 1976 11204.60 11483.10 11384.45 11380.10 0.90 
Hispanic ancestry 988 11031.90 11337.50 11189.15 11185.14 1.56 
Asian ancestry  437 11266.40 11443.50 11375.10 11371.81 1.48 
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Type II Diabetes 2012 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
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Type II Diabetes (2014) 
GWAS Summary Statistic Source: Mahajan, Anubha et al. 2014. “Genome-Wide Trans-Ancestry Meta-Analysis 
Provides Insight into the Genetic Architecture of Type 2 Diabetes Susceptibility.” Nature Genetics 46(3):234–44. 
 
 
GWAS Ancestry Group(s): European (Ncase = 12,171, Ncontrol = 56,862), East Asian (Ncase = 6,952, Ncontrol = 
11,865), South Asian (Ncase = 5,561, Ncontrol = 14,458), Mexican/Mexican American (Ncase = 1,804, Ncontrol 
= 779).  
 
 
The PGSs for Type II Diabetes 2014 were created using GWAS meta-analysis results from a 2014 study 
conducted by the DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium, the Asian Genetic 
Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, the South Asian Type 2 Diabetes (SAT2D) 
Consortium, the Mexican American Type 2 Diabetes (MAT2D) Consortium, and the Type 2 Diabetes Genetic 
Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium. The GWAS meta-
analysis files are publically available from: http://www.diagram-consortium.org/downloads.html.  
 
The discovery meta-analysis consists of 26,488 T2D cases and 83,964 controls in populations of European, East 
Asian, south Asian, and Mexican and Mexican American descent as described above. The replication meta-
analysis consisted of 21,491 cases and 55,647 controls in populations of European descent. Study-specific 
GWAS adjustments varied, but largely included: age, sex, and cohort.  
 
The Add Health PGSs for Type II Diabetes 2014 (T2D_2014) are standardized (mean=0, standard deviation = 1) 
within ancestry groups to control for population stratification. To give researchers an idea of the underlying 
raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please 
read the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 12385.00 12610.40 12488.40 12488.85 0.35 
African ancestry 1976 12514.40 12799.50 12666.45 12665.83 0.95 
Hispanic ancestry 988 12460.10 12657.80 12548.70 12548.90 1.07 
Asian ancestry  437 12543.30 12676.70 12617.90 12617.14 1.26 
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Type II Diabetes 2014 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
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Body Mass Index  
GWAS Summary Statistic Source: Locke, Adam E. et al. 2015. “Genetic Studies of Body Mass Index Yield New 
Insights for Obesity Biology.” Nature 518(7538):197–206. 
 
GWAS Ancestry Group(s): European  
 
 
PGSs for body mass index BMI were created using results from a 2015 GWAS conducted by the Genetic 
Investigation of ANthropometric Traits (GIANT) consortium. The GWAS meta-analysis files are publicly available 
from: http://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files.  
 
Joint GWAS and Metabochip meta-analysis was performed on a sample of 332,206 (Ngwas = 234,069; Nmeta = 
88,137) individuals of European descent from 114 studies.  Additional covariates controlled for during the 
meta-analysis include: age, the second order polynomial of age, sex, and genetic principal components. The 
measures of BMI include clinical measurements as well as self-reported BMI.  
 
The Add Health BMI are standardized (mean=0, standard deviation = 1) within ancestry groups to control for 
population stratification. To give researchers an idea of the underlying raw PGS, we present a few descriptive 
statistics and density plots for the unstandardized PGSs below. Please read the section entitled “Using Add 
Health PGSs” in the introductory portion of this document prior to conducting any analyses using the 
provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 2422.74 2481.28 2451.45 2451.41 0.10 
African ancestry 1976 2464.99 2513.17 2493.17 2492.84 0.16 
Hispanic ancestry 988 2440.33 2491.33 2465.80 2465.47 0.28 
Asian ancestry  437 2463.94 2505.61 2482.60 2482.65 0.31 
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European ancestry raw PGS distribution 
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Waist Circumference 
GWAS Summary Statistic Source: Shungin, Dmitry et al. 2015. “New Genetic Loci Link Adipose and 
Insulin Biology to Body Fat Distribution.” Nature 518(7538):187–96. 
 
GWAS Ancestry Group(s): European  
 
 
PGSs for waist circumference were created using results from a 2015 study conducted by the Genetic 
Investigation of ANthropometric Traits (GIANT) consortium. The GWAS meta-analysis files are publicly available 
from: http://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files.  
 
A GWAS meta-analysis was performed on a sample of 142,762 individuals of European descent from 57 studies, 
and separately in a Metabochip (MC) meta-analysis on a sample of 67,326 individuals of European descent 
from 44 studies. A joint GWAS and MC meta-analysis was then conducted on 210,088 individuals of European 
descent. Additional covariates in both GWAS and MC analyses included: age, the second order polynomial of 
age, study-specific covariates as necessary, and BMI.  
 
The Add Health PGSs for waist circumference (WC)are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification. To give researchers an idea of the underlying raw PGS, 
we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 2749.61 2815.32 2786.25 2786.09 0.11 
African ancestry 1976 2767.46 2810.61 2789.13 2789.07 0.14 
Hispanic ancestry 988 2755.17 2816.33 2786.98 2786.93 0.26 
Asian ancestry  437 2763.07 2806.59 2784.93 2784.75 0.34 
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Waist Circumference 
 
European ancestry raw PGS distribution 
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Waist-to-Hip Ratio 
GWAS Summary Statistic Source: Shungin, Dmitry et al. 2015. “New Genetic Loci Link Adipose and 
Insulin Biology to Body Fat Distribution.” Nature 518(7538):187–96. 
 
GWAS Ancestry Group(s): European  
 
 
PGSs for waist-to-hip ratio were created using results from a 2015 study conducted by the Genetic 
Investigation of ANthropometric Traits (GIANT) consortium. The GWAS meta-analysis files are publicly available 
from: http://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files.  
 
GWAS meta-analysis was performed on a sample of 142,762 individuals of European descent from 57 studies, 
and separately in a Metabochip (MC) meta-analysis on a sample of 67,326 individuals of European descent 
from 44 studies. A joint GWAS and MC meta-analysis was then conducted on 210,088 individuals of European 
descent. Additional covariates in both GWAS and MC analyses included: age, the second order polynomial of 
age, study-specific covariates as necessary, and BMI.  
 
The Add Health PGSs for waist-to-hip ratio (WHR) are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification. To give researchers an idea of the underlying raw PGS, 
we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 2731.39 2790.66 2759.54 2759.54 0.11 
African ancestry 1976 2732.57 2773.93 2753.56 2753.56 0.14 
Hispanic ancestry 988 2734.54 2799.52 2770.01 2769.84 0.30 
Asian ancestry  437 2773.34 2816.04 2796.13 2796.30 0.32 
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Waist-to-Hip Ratio
European ancestry raw PGS distribution 
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Height 
GWAS Summary Statistic Source: Wood, Andrew R. et al. 2014. “Defining the Role of Common Variation in the 
Genomic and Biological Architecture of Adult Human Height.” Nature Genetics 46(11):1173–86. 
 
GWAS Ancestry Group(s): European  
 
 
PGSs for height were created using results from a 2014 study conducted by the Genetic Investigation of 
ANthropometric Traits (GIANT) consortium. The GWAS meta-analysis files are publicly available 
from: http://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files.  
 
The meta-analysis included 253,288 individuals of European descent from 79 studies imputed to HapMap II. 
Replication was performed in a sample of 80,067 individuals of European descent. Height was measured as sex 
standardized height. Additional covariates in GWAS analyses included age and genetic principal components.  
 
The Add Health PGSs for height are standardized (mean=0, standard deviation = 1) within ancestry groups to 
control for population stratification. To give researchers an idea of the underlying raw PGS, we present a few 
descriptive statistics and density plots for the unstandardized PGSs below. Please read the section entitled 
“Using Add Health PGSs” in the introductory portion of this document prior to conducting any analyses using 
the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 3045.60 3195.98 3144.46 3143.05 0.22 
African ancestry 1976 2967.68 3066.18 3002.63 3004.19 0.35 
Hispanic ancestry 988 3021.99 3159.78 3073.92 3077.56 0.77 
Asian ancestry  437 2952.41 3049.39 2977.41 2979.34 0.69 
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European ancestry raw PGS distribution 
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Menarche  
GWAS Summary Statistic Source: Perry, John R. B. et al. 2014. “Parent-of-Origin-Specific Allelic Associations 
among 106 Genomic Loci for Age at Menarche.” Nature 514(7520):92–97. 
 
GWAS Ancestry Group(s): European 
 
 
PGSs for age at menarche were created using results from a 2014 study conducted by the Reproductive 
Genetics (ReproGen) consortium. The GWAS meta-analysis files are publicly available 
from: http://www.reprogen.org/data_download.html.  
 
The discovery meta-analysis included 132,989 women of European descent from 58 studies. Women who 
reported their age at menarche as less than 9 years or greater than 17 years old were excluded from the 
analysis. Analyses adjusted for birth year in order to account for secular trends in menarche timing, study-
specific genomic control inflation factors, and relatedness between individuals when necessary.  
 
The Add Health PGSs for age at menarche are standardized (mean=0, standard deviation = 1) within ancestry 
groups to control for population stratification. To give researchers an idea of the underlying raw PGS, we 
present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -31.94 56.72 13.12 13.12 0.16 
African ancestry 1976 -37.87 29.73 -9.41 -9.16 0.21 
Hispanic ancestry 988 -30.55 37.63 4.25 4.03 0.37 
Asian ancestry  437 -30.68 33.62 -1.18 -0.78 0.51 
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Menopause 
GWAS Summary Statistic Source: Day, Felix R. et al. 2015. “Large-Scale Genomic Analyses Link Reproductive 
Aging to Hypothalamic Signaling, Breast Cancer Susceptibility and BRCA1-Mediated DNA Repair.” Nature 
Genetics 47(11):1294–1303. 
 
GWAS Ancestry Group(s): European  
 
 
PGSs for age at menarche were created using results from a 2014 study conducted by the Reproductive 
Genetics (ReproGen) consortium. The GWAS meta-analysis files are publicly available 
from: http://www.reprogen.org/data_download.html.  
 
The ReproGen meta-analysis included 69,360 women of European descent from 50 studies imputed to HapMap 
Phase 2.  GWAS analyses included study specific controls and the top principal components of the genetic data. 
In all studies, age at naturally occurring menopause is self-reported. Age at menopause is defined as the age at 
last occurring menstrual period followed by 12 consecutive months of amenorrhea. 
 
The Add Health PGSs for age at menopause are standardized (mean=0, standard deviation = 1) within ancestry 
groups to control for population stratification. To give researchers an idea of the underlying raw PGS, we 
present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -242.18 150.34 -71.96 -72.31 0.64 
African ancestry 1976 -95.72 136.28 25.60 24.59 0.73 
Hispanic ancestry 988 -166.67 81.51 -34.61 -35.82 1.28 
Asian ancestry  437 -74.20 124.05 15.33 14.22 1.62 
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Number of Children Ever Born 
GWAS Summary Statistic Source: Barban, Nicola et al. 2016. “Genome-Wide Analysis Identifies 12 Loci 
Influencing Human Reproductive Behavior.” Nature Genetics 48(12):1462–72. 
 
GWAS Ancestry Group(s): European  
 
 
PGSs for the number of children ever born were created using pooled results for men and women from a 2016 
study conducted as part of the Sociogenome project (http://www.sociogenome.com/). The GWAS meta-
analysis files are publicly available 
from: ftp://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/BarbanN_27798627_GCST003796.  
 
The meta-analysis included 343,072 individuals of European descent above age 44 for women and 54 for men 
from 62 studies. Additional covariates include age, the second order polynomial of age, the third order 
polynomial of age, and genetic principal components.  
 
The Add Health PGSs for number of children ever born (NEB) are standardized (mean=0, standard deviation = 
1) within ancestry groups to control for population stratification. To give researchers an idea of the underlying 
raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please 
read the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 1689.86 11668.10 6632.36 6601.49 19.16 
African ancestry 1976 -464.23 6476.07 2430.67 2424.28 23.50 
Hispanic ancestry 988 1553.43 10455.40 5708.17 5716.19 42.78 
Asian ancestry  437 1358.46 7940.91 4808.55 4828.68 51.64 
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Age at First Birth 
GWAS Summary Statistic Source: Barban, Nicola et al. 2016. “Genome-Wide Analysis Identifies 12 Loci 
Influencing Human Reproductive Behavior.” Nature Genetics 48(12):1462–72. 
 
GWAS Ancestry Group(s): European  
 
 
PGSs for the age at first birth were created using pooled results for men and women from a 2016 study 
conducted as part of the Sociogenome project (http://www.sociogenome.com/). The GWAS meta-analysis files 
are publicly available 
from: ftp://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/BarbanN_27798627_GCST003795.  
 
The meta-analysis included 251,151 individuals of European descent who had a biological child at the time of 
interview from 62 studies. Additional covariates include age, the second order polynomial of age, the third 
order polynomial of age, and genetic principal components.  
 
The Add Health PGSs for age at first birth (AFB) are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification. To give researchers an idea of the underlying raw PGS, 
we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
  
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -4844.29 7307.43 1385.73 1420.20 20.49 
African ancestry 1976 -2795.67 4871.18 443.44 465.42 24.50 
Hispanic ancestry 988 -3552.22 5604.14 808.56 823.98 48.18 
Asian ancestry  437 -4520.84 3004.46 -426.29 -520.61 60.07 
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Ever/Current Smoker  
GWAS Summary Statistic Source: Furberg, Helena et al. 2010. “Genome-Wide Meta-Analyses Identify Multiple 
Loci Associated with Smoking Behavior.” Nature Genetics 42(5):441–47. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for current/ever smoker were created using results from a 2010 GWAS conducted by the Tobacco 
and Genetics (TAG) Consortium. The GWAS meta-analysis files are publicly available 
from: https://www.med.unc.edu/pgc/results-and-downloads.  
 
The discovery phase of analysis included 74,053 individuals of European descent. The replication of the 15 most 
significant genetic regions included 143,023 individuals. Individuals who were recorded as having ever been 
regular smokers were defined as those who reported having smoked at least 100 cigarettes during their 
lifetime, and never regular smokers were defined as those who reported having smoked between 0 and 99 
cigarettes during their lifetime. GWAS analyses controlled for imputed allele dosage for a SNP and if the 
individual was classified as a case in the primary study. If the primary study was case-control in design and the 
phenotype being studied was known to be associated with smoking, the GWAS adjusted for case status to 
reduce potential confounding. Analyses were run and meta-analyzed separately for males and females.  
 
The Add Health current/ever smoker (Evrsmk) are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification, but to give researchers an idea of the underlying raw 
PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read 
the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 8987.39 9165.44 9088.74 9089.02 0.29 
African ancestry 1976 9034.84 9162.08 9093.27 9093.16 0.43 
Hispanic ancestry 988 9023.06 9176.04 9104.48 9104.68 0.70 
Asian ancestry  437 9063.89 9188.32 9123.72 9122.90 0.92 
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Ever/Current Smoker 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
 
  
49 
 
Number of Cigarettes per day  
GWAS Summary Statistic Source: Furberg, Helena et al. 2010. “Genome-Wide Meta-Analyses Identify Multiple 
Loci Associated with Smoking Behavior.” Nature Genetics 42(5):441–47. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for the number of cigarettes smoked per day were created using results from a 2010 GWAS 
conducted by the Tobacco and Genetics (TAG) Consortium. The GWAS meta-analysis files are publicly available 
from: https://www.med.unc.edu/pgc/results-and-downloads.  
 
The discovery phase of analysis included 74,053 individuals of European descent. The replication of the 15 most 
significant genetic regions included 143,023 individuals. The number of cigarettes smoked per day was 
reported as either the average number of cigarettes smoked per day or the maximum number of cigarettes 
smoked in a single day (see the online methods). GWAS analyses controlled for imputed allele dosage for a SNP 
and if the individual was classified as a case in the primary study. If the primary study was case-control in 
design and the phenotype being studied was known to be associated with smoking, the GWAS adjusted for 
case status to reduce potential confounding. Analyses were run and meta-analyzed separately for males and 
females.  
 
The Add Health cigarettes smoked per day (CPD)are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification, but to give researchers an idea of the underlying raw 
PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read 
the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 63864.60 64915.30 64440.40 64439.87 1.90 
African ancestry 1976 63381.10 64369.40 63815.55 63815.89 3.38 
Hispanic ancestry 988 63681.90 64694.10 64201.75 64200.37 5.46 
Asian ancestry  437 63464.00 64328.40 63865.70 63869.95 6.68 
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Number of Cigarettes per Day
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Extraversion 
GWAS Summary Statistic Source: van den Berg, Stéphanie M. et al. 2016. “Meta-Analysis of Genome-Wide 
Association Studies for Extraversion: Findings from the Genetics of Personality Consortium.” Behavior Genetics 
46(2):170–82. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for extraversion were created using results from a 2016 study by the Genetics of Personality 
Consortium (GPC). Summary statistics are publicly available from: www.tweelingenregister.org/GPC/. 
 
The discovery meta-analysis included 63,030 individuals of European descent from 29 cohorts. The replication 
analysis consisted of 9,783 individuals, also of European descent, from a single cohort. All cohorts imputed 
SNPs based on the 1000 genomes reference panel (1000G). Additional study-specific covariates included sex, 
age, and ancestry principal components of the genetic data. Extraversion was measured as a continuous latent 
variable as described in van den Berg et al. (2014).  
  
The Add Health PGSs for Extraversion are standardized (mean=0, standard deviation = 1) within ancestry 
groups to control for population stratification. To give researchers an idea of the underlying raw PGS, we 
present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -43.87 30.38 -12.37 -12.27 0.12 
African ancestry 1976 -42.10 7.68 -17.30 -17.53 0.16 
Hispanic ancestry 988 -54.19 8.11 -23.29 -23.16 0.33 
Asian ancestry  437 -59.13 -16.55 -38.94 -39.22 0.39 
 
 
 
 
 
References: 
van den Berg, Stéphanie M. et al. 2014. “Harmonization of Neuroticism and Extraversion Phenotypes across  
Inventories and Cohorts in the Genetics of Personality Consortium: An Application of Item Response 
Theory.” Behavior Genetics 44(4):295–313.  
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Extraversion 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Attention-Deficit/Hyperactivity Disorder (2010)   
GWAS Summary Statistic Source: Neale, Benjamin M. et al. 2010. “Meta-Analysis of Genome-Wide Association 
Studies of Attention-Deficit/Hyperactivity Disorder.” Journal of the American Academy of Child & Adolescent 
Psychiatry 49(9):884–97. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for attention-deficit/hyperactivity disorder 2010 were created using results from a 2010 GWAS 
conducted by the ADHD subgroup of the Psychiatric GWAS Consortium. The GWAS meta-analysis files are 
publicly available from: http://www.med.unc.edu/pgc/results-and-downloads (pgc.adhd.full.2012-10.txt).  
 
The meta-analysis included 2,064 trios, 896 cases, and 2,455 controls from four projects: (1) the Children’s 
Hospital of Philadelphia (CHOP), (2) phase I of the International Multisite ADHD Genetics Project (IMAGE), (3) 
phase II of IMAGE (IMAGE II), and (4) the Pfizer funded study from the University of California, Los Angeles, 
Washington University, and the Massachusetts General Hospital (PUWMa). Measures of attention deficit 
disorder were harmonized across samples and were based on a combination of semi-structured interviews and 
parent and/or teacher report on questionnaires (see Neale et al., p. 3-5, 2010).  
 
The Add Health PGSs for attention-deficit/hyperactivity disorder 2010 (ADHD_2010) are standardized (mean=0, 
standard deviation = 1) within ancestry groups to control for population stratification. To give researchers an 
idea of the underlying raw PGS, we present a few descriptive statistics and density plots for the unstandardized 
PGSs below. Please read the section entitled “Using Add Health PGSs” in the introductory portion of this 
document prior to conducting any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 3630.02 12266.40 7932.60 7947.99 14.96 
African ancestry 1976 972.29 7048.82 3631.97 3664.49 20.43 
Hispanic ancestry 988 3132.62 9977.56 6985.96 7003.93 34.83 
Asian ancestry  437 3133.78 8907.47 6022.31 6047.66 41.20 
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Attention Deficit Disorder 2010 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Attention-Deficit/Hyperactivity Disorder (2017)   
GWAS Summary Statistic Source: Demontis, Ditte et al. 2017. “Discovery Of The First Genome-Wide Significant 
Risk Loci For ADHD.” BioRxiv 145581.  
(This is a pre-print version of the study which is currently in press. http://orca.cf.ac.uk/110923/) 
 
GWAS Ancestry Group(s): European (Ncases = 19,099; Ncontrols = 34,194), Han Chinese (Ncases = 1,040; 
Ncontrol = 963); Multi-ethnic (PUWMa sample with N = 78) 
 
 
The PGSs for attention-deficit/hyperactivity disorder 2017 PGSs were created using results from a 2017 BioRxiv 
preprint from the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) and Psychiatric 
Genetics Consortium (PGC). The GWAS meta-analysis files are publicly available 
from: http://www.med.unc.edu/pgc/results-and-downloads (Download ADHD GWAS - June 2017).  
 
The discovery meta-analysis included 55,374 individuals (20,183 cases and 35,191 controls) from 12 studies of 
mixed ancestry while the replication sample included 93,916 individuals from two cohorts of multiple ancestry 
groups. Additional covariates included study specific controls and genetic ancestry principal components.  
  
 
The Add Health PGSs for attention-deficit/hyperactivity disorder 2017 (ADHD_2017) are standardized (mean=0, 
standard deviation = 1) within ancestry groups to control for population stratification. To give researchers an 
idea of the underlying raw PGS, we present a few descriptive statistics and density plots for the unstandardized 
PGSs below. Please read the section entitled “Using Add Health PGSs” in the introductory portion of this 
document prior to conducting any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -373.65 -180.42 -273.61 -273.70 0.35 
African ancestry 1976 -275.51 -122.68 -199.21 -198.88 0.47 
Hispanic ancestry 988 -345.63 -178.30 -255.54 -255.59 0.80 
Asian ancestry  437 -277.52 -160.05 -222.46 -222.73 1.06 
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Attention Deficit Disorder 2017 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Bipolar Disorder  
GWAS Summary Statistic Source: Psychiatric GWAS Consortium Bipolar Disorder Working Group. 2011. “Large-
Scale Genome-Wide Association Analysis of Bipolar Disorder Identifies a New Susceptibility Locus near ODZ4.” 
Nature Genetics 43(10):977–83. 
 
GWAS Ancestry Group(s): European 
 
 
The PGSs for bipolar disorder were created using results from a 2011 GWAS conducted by the Bipolar Disorder 
working group of the Psychiatric GWAS Consortium. The GWAS meta-analysis files are publicly available 
from: http://www.med.unc.edu/pgc/results-and-downloads (pgc.bip.2012-04.zip).  
 
The discovery phase of the meta-analysis included 7,481 cases and 9,250 controls. The replication phase of the 
34 most significant genetic regions identified in the discovery phase was conducted in a sample of 4,496 cases 
and 42,422 controls. Samples were drawn from 11 studies (see Table 1 and supplemental materials, from the 
original publication). All analyses adjusted for the top five principal components of the genetic data and study 
fixed effects. Bipolar disorder was measured as diagnoses of either: bipolar disorder type 1, bipolar disorder 
type 2, schizoaffective disorder bipolar, and a few cases with other bipolar diagnoses (p. 997).  
 
The Add Health PGSs for bipolar disorder (BP) are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification, but to give researchers an idea of the underlying raw 
PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read 
the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 52.44 376.12 229.96 229.63 0.60 
African ancestry 1976 -60.16 201.54 71.35 72.77 0.81 
Hispanic ancestry 988 27.50 368.26 214.10 214.64 1.40 
Asian ancestry  437 17.17 247.92 130.03 130.60 1.69 
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Bipolar Disorder 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Major Depressive Disorder (2013)  
GWAS Summary Statistic Source: Ripke, Stephan et al. 2013. “A Mega-Analysis of Genome-Wide Association 
Studies for Major Depressive Disorder.” Molecular Psychiatry 18(4):497–511. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for major depressive disorder 2013 were created using results from a 2013 GWAS conducted by the 
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. The GWAS meta-analysis files 
are publicly available from: https://www.med.unc.edu/pgc/results-and-downloads.  
 
The MDD GWAS combined meta-analysis included 9,240 cases and 9,519 controls (N=18,759). The replication 
sample consisted of 6,783 cases and 50,695 controls. Study level fixed effects and the first five genetic principal 
components were included as covariates. Analyses were also stratified by sex, recurrent MDD, recurrent early-
onset MDD, age of onset, pre-pubertal onset MDD, and latent classes of MDD criteria.  
 
The Add Health major depressive disorder 2013 (MDD_2013) are standardized (mean=0, standard deviation = 
1) within ancestry groups to control for population stratification. To give researchers an idea of the underlying 
raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please 
read the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -45.37 -0.18 -20.77 -20.81 0.08 
African ancestry 1976 -31.68 11.70 -11.21 -11.23 0.13 
Hispanic ancestry 988 -34.42 7.45 -15.62 -15.62 0.19 
Asian ancestry  437 -23.22 9.22 -7.17 -7.21 0.27 
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Major Depressive Disorder 2013 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Major Depressive Disorder (2018)  
GWAS Summary Statistic Source: Wray, Naomi R. et al. 2018. “Genome-Wide Association Analyses Identify 44 
Risk Variants and Refine the Genetic Architecture of Major Depression.” Nature Genetics 50(5):668–81. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for major depressive disorder 2018 were created using results from a 2018 GWAS conducted by the 
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. The GWAS meta-analysis files 
are publicly available from: https://www.med.unc.edu/pgc/results-and-downloads.  
 
The MDD 2018 GWAS combined meta-analysis included 135,458 cases and 344,901 controls (N = 480,359) from 
35 studies of individuals of European descent. Due to data sharing restrictions from 23andMe, the PGSs are 
based on summary statistics that exclude the 23andMe cohort (Ncase = 75,607; Ncontrols = 231,747). MDD is 
cases are based on meeting standard criteria for major depressive disorder.  
 
The Add Health PGSs for major depressive disorder 2018 (MDD_2018) are standardized (mean=0, standard 
deviation = 1) within ancestry groups to control for population stratification. To give researchers an idea of the 
underlying raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs 
below. Please read the section entitled “Using Add Health PGSs” in the introductory portion of this 
document prior to conducting any analyses using the provided PGSs. 
 
 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 -5603.43 -5373.96 -5528.12 -5526.08 0.31 
African ancestry 1976 -4310.80 -3143.47 -3615.33 -3638.27 4.23 
Hispanic ancestry 988 -5535.19 -4882.16 -5352.34 -5335.70 3.75 
Asian ancestry  437 -5426.82 -5157.03 -5312.56 -5310.87 1.39 
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Major Depressive Disorder 2018 
 
European ancestry raw PGS distribution 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
Asian ancestry raw PGS distribution 
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Schizophrenia  
GWAS Summary Statistic Source: Ripke, Stephan et al. 2014. “Biological Insights from 108 Schizophrenia-
Associated Genetic Loci.” Nature 511(7510):421–27. 
 
GWAS Ancestry Group(s): European and East Asian [Japan, Singapore, Hong Kong and Sichuan China] (Ncases = 
1,866; Ncontrols = 3,418)  
 
 
The PGSs for schizophrenia were created using results from a 2014 GWAS conducted by the Schizophrenia 
Working Group of the Psychiatric Genomics Consortium (PGC). The GWAS meta-analysis files are publicly 
available from: https://www.med.unc.edu/pgc/results-and-downloads. 
 
The schizophrenia GWAS combined meta-analysis included 36,989 cases and 113,075 controls (N=150,064) 
from individuals of European and East Asian descent. The replication sample consisted of 1,513 cases and 
66,236 controls from individuals of European descent. To enable acquisition of large samples, some of the 
participating groups ascertained cases via clinician diagnosis rather than a research-based assessment. Genetic 
principal components and study fixed effects were included as covariates.  
 
The Add Health schizophrenia (SCZ) are standardized (mean=0, standard deviation = 1) within ancestry groups 
to control for population stratification. To give researchers an idea of the underlying raw PGS, we present a few 
descriptive statistics and density plots for the unstandardized PGSs below. Please read the section entitled 
“Using Add Health PGSs” in the introductory portion of this document prior to conducting any analyses using 
the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 7968.42 8247.90 8119.95 8119.10 0.59 
African ancestry 1976 8180.00 8448.73 8344.16 8341.85 0.93 
Hispanic ancestry 988 8044.11 8343.57 8190.51 8189.40 1.61 
Asian ancestry  437 8179.38 8387.42 8274.14 8278.68 1.92 
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Schizophrenia  
 
European ancestry raw PGS distribution 
 
 
 
Hispanic ancestry raw PGS distribution 
 
 
African ancestry raw PGS distribution 
 
 
 
Asian ancestry raw PGS distribution 
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Mental Health Cross Disorder 
GWAS Summary Statistic Source: Cross-Disorder Group of the Psychiatric Genomics Consortium. 2013. 
“Identification of Risk Loci with Shared Effects on Five Major Psychiatric Disorders: A Genome-Wide Analysis.” 
Lancet (London, England) 381(9875):1371–79. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for mental health cross-disorder were created using results from a 2013 GWAS conducted by the 
Cross Disorder working group of the Psychiatric GWAS Consortium. The GWAS meta-analysis files are publicly 
available from: http://www.med.unc.edu/pgc/results-and-downloads (pgc.cross.full.2013-03.zip).  
 
The discovery phase of the meta-analysis included 33,342 cases and 27,888 controls. Disorders that were 
counted as cases (DSM-III-R or DSM-IV criteria) included autism spectrum disorder, attention-
deficit/hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia.  
 
The Add Health PGSs for mental health cross-disorder (XDIS) are standardized (mean=0, standard deviation = 1) 
within ancestry groups to control for population stratification. To give researchers an idea of the underlying 
raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please 
read the section entitled “Using Add Health PGSs” in the introductory portion of this document prior to 
conducting any analyses using the provided PGSs. 
 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 188.20 385.08 304.70 302.47 0.36 
African ancestry 1976 130.32 290.89 203.32 203.77 0.56 
Hispanic ancestry 988 235.51 398.57 319.01 318.42 0.79 
Asian ancestry  437 249.04 379.93 320.72 321.30 0.90 
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Cross Disorder 
 
European ancestry raw PGS distribution 
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Alzheimer’s Disease  
GWAS Summary Statistic Source: Lambert, Jean-Charles et al. 2013. “Meta-Analysis of 74,046 Individuals 
Identifies 11 New Susceptibility Loci for Alzheimer’s Disease.” Nature Genetics 45(12):1452–58. 
 
GWAS Ancestry Group(s): European  
 
 
The PGSs for Alzheimer’s disease were created using results from a 2013 GWAS conducted by the International 
Genomics of Alzheimer’s Project (IGAP). The GWAS meta-analysis files are publicly available 
from: http://web.pasteur-lille.fr/en/recherche/u744/igap/igap_download.php.  
 
The meta-analysis of Alzheimer’s disease included 54,162 participants (cases=17,008 and controls=37,154) of 
European decent imputed to 1000 Genomes 2010 release. The replication sample included 19,884 participants 
of European ancestry (cases=8,572 and controls=11,312). Additional covariates included in the GWAS for each 
contributing cohort included age, sex, and genetic principal components. 
 
The Add Health PGSs for Alzheimer’s disease (AD) are standardized (mean=0, standard deviation = 1) within 
ancestry groups to control for population stratification. To give researchers an idea of the underlying raw PGS, 
we present a few descriptive statistics and density plots for the unstandardized PGSs below. Please read the 
section entitled “Using Add Health PGSs” in the introductory portion of this document prior to conducting 
any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 9485.12 9685.55 9592.68 9592.61 0.35 
African ancestry 1976 9765.04 9990.86 9899.59 9897.14 0.80 
Hispanic ancestry 988 9525.81 9748.33 9646.47 9646.80 1.06 
Asian ancestry  437 9654.28 9810.60 9726.27 9727.17 1.18 
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Alzheimer’s Disease 
 
European ancestry raw PGS distribution 
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Educational Attainment (2016) 
GWAS Summary Statistic Source: Okbay, Aysu et al. 2016. “Genome-Wide Association Study Identifies 74 Loci 
Associated with Educational Attainment.” Nature 533(7604):539–42. 
 
GWAS Ancestry Group(s): European  
 
 
The educational attainment 2016 PGSs were created using results from a 2016 study by the Social Science 
Genetic Association Consortium (SSGAC). The GWAS meta-analysis files are publicly available 
from: https://www.thessgac.org/data.  
 
Due to data sharing restrictions from 23andMe, the PGSs are based on summary statistics that exclude the 
23andMe cohort. Study-specific GWASs controlled for the first ten principal components of the genotypic data, 
age, a second-order polynomial of age, a third-order polynomial in age, an indicator for being female, 
interactions between age and female, and study-specific controls, including dummy variables for major events 
such as wars or policy changes that may have affected access to education in their specific sample.  
 
The Add Health PGSs for educational attainment 2016 (EDU_2016) are standardized (mean=0, standard 
deviation = 1) within ancestry groups to control for population stratification. To give researchers an idea of the 
underlying raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs 
below. Please read the section entitled “Using Add Health PGSs” in the introductory portion of this 
document prior to conducting any analyses using the provided PGSs. 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 1890.33 1936.13 1910.81 1910.77 0.08 
African ancestry 1976 1884.97 1918.69 1899.27 1899.45 0.10 
Hispanic ancestry 988 1890.18 1926.79 1907.27 1907.65 0.18 
Asian ancestry  437 1891.95 1923.16 1904.93 1905.06 0.23 
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Educational Attainment 2016 
 
European ancestry raw PGS distribution 
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Educational Attainment (2018) 
GWAS Summary Statistic Source: "Gene discovery and polygenic prediction from a 1.1-million-person GWAS of 
educational attainment", Lee et al., Nature Genetics, 2018. (forthcoming). 
 
GWAS Ancestry Group(s): European  
 
 
The educational attainment 2018 PGSs were created using results from a forthcoming 2018 study by the Social 
Science Genetic Association Consortium (SSGAC). The GWAS meta-analysis files are publicly available 
from: https://www.thessgac.org/data. Due to data sharing restrictions from 23andMe, the PGSs are based on 
summary statistics that exclude the 23andMe cohort.  
 
The discovery meta-analysis of educational attainment 2018 included 1,131,881 individuals of European decent 
imputed to 1000 Genomes 2010 release. 
  
The Add Health PGSs for educational attainment 2018 (EDU_2018) are standardized (mean=0, standard 
deviation = 1) within ancestry groups to control for population stratification. To give researchers an idea of the 
underlying raw PGS, we present a few descriptive statistics and density plots for the unstandardized PGSs 
below. Please read the section entitled “Using Add Health PGSs” in the introductory portion of this 
document prior to conducting any analyses using the provided PGSs. 
 
 
 
 
 
 
PGS Summary Statistics by Ancestry 
Group N Min Max Median Mean SE (mean) 
European ancestry 5728 16.96 62.26 41.77 41.83 0.08 
African ancestry 1976 3.96 43.04 21.88 22.05 0.13 
Hispanic ancestry 988 24.90 60.35 40.48 40.80 0.18 
Asian ancestry  437 31.43 59.21 45.30 45.36 0.23 
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Educational Attainment 2018 
 
European ancestry raw PGS distribution 
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